Pain medicine (Malden, Mass.)
Pain outcomes in persons with multiple sclerosis receiving S1PR modulators: A cross-sectional study.
Salvador Sierra, Anna L Kratz, Tiffany J Braley
Published: 202610.1093/pm/pnag008
Abstract
BACKGROUND: The impact of disease-modifying therapies (DMT) on chronic pain in multiple sclerosis (MS) is poorly understood. Preclinical research suggests that modulation of sphingosine-1-phosphate pathways involved in inflammation and central sensit…
Preview only. Read the full abstract at the source